Unlock instant, AI-driven research and patent intelligence for your innovation.
Chinese medicinal composition for treating arteriosclerosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technique for arteriosclerosis and composition, which is applied in the field of traditional Chinese medicine compositions for the treatment of arteriosclerosis, can solve the problems of no specific medicine for arteriosclerosis and the like, and achieves the effects of significant curative effect, good tolerance and improvement of endothelial function.
Inactive Publication Date: 2008-11-12
刘昌州
View PDF0 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] There is currently no specific drug for arteriosclerosis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0023] Take mint 1g, chrysanthemum 1g, cohosh 1g, peony bark 1g, rhubarb 1g, kansui 1g, andrographis 1g, psyllium 1g, wood 1g, tangerine peel 2g, Guanzhong 2g, skullcap 4g, cassia 4g, red Flower 4g, Salvia 4g, Dilong 4g, Frankincense 4g, Jasper Powder 4g. The above medicines are mixed and decocted in water, concentrated, and made into granules, 2-3 times a day, 1 gram each time, orally.
Embodiment 2
[0025] Take mint 2g, chrysanthemum 2g, cohosh 2g, peony 2g, rhubarb 2g, kansui 2g, andrographis 2g, psyllium 2g, mutong 2g, tangerine peel 4g, guanzhong 4g, skullcap 4g, cassia 4g, red Flower 4g, Salvia 4g, Dilong 4g, Frankincense 4g, Jasper Powder 4g. The above medicines are mixed and decocted in water, concentrated, and made into water decoction according to the conventional method, 2-3 times a day, orally.
Embodiment 3
[0027] Take mint 1g, chrysanthemum 1g, cohosh 1g, peony 1g, rhubarb 2g, kansui 2g, andrographis 2g, psyllium 2g, mutong 2g, tangerine peel 2g, guanzhong 4g, skullcap 2g, cassia 3g, red Flower 3g, Salvia 3g, Dilong 3g, Frankincense 4g, Jasper Powder 2g. The above medicines are mixed and decocted in water, concentrated, and made into capsules according to the conventional method, 2-3 times a day, 2 capsules each time, orally.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a medicine, particularly relating to a Chinese medicine composition for treating arteriosclerosis. The Chinese medicine composition for treating arteriosclerosis is characterized in that the mass portions of the components are: 1 to 2 grams of mint, 1 to 2 grams of chrysanthemum, 1 to 2 grams of cimicifuga foetida, 1 to 2 grams of bark of tree peony root, 1 to 2 grams of rhubarb, 1 to 2 grams of euphorbia kansui, 1 to 2 grams of common andrographisherb, 1 to 2 grams of asiatic plantain seed, 1 to 2 grams of akebia stem, 2 to 4 grams of orange peel, 2 to 4 grams of cyrtomiumrhizome, 2 to 4 grams of baical skullcap root, 2 to 4 grams of abalone shell, 2 to 4 grams of safflower, 2 to 4 grams of salvia, 2 to 4 grams of earthworm, 2 to 4 grams of frankincense and 2 to 4 grams of jasper powder. The medicine of the invention is safe, effective and good in tolerance, so that the medicine can be routinely prescribed to treat a patient with carotid atherosclerosis and prevent cardiocerebrovascular events and has the advantages of safety and reliability, obvious curative effect, small side effect and high cure rate.
Description
(1) Technical field [0001] The invention relates to a medicine, in particular to a traditional Chinese medicine composition for treating arteriosclerosis. (2) Background technology [0002] Arteriosclerosis is a non-inflammatory disease of the arteries that can thicken, harden, lose elasticity and narrow the lumen of the arterial wall. There are three main types of arteriosclerosis: (1) small arteriosclerosis; (2) medial arteriosclerosis; (3) atherosclerosis. Arteriosclerosis is a vascular disease that occurs with age, and its regularity usually occurs in adolescence, and becomes aggravated and onset in middle-aged and old age. More men than women, the disease has gradually increased in my country in recent years, becoming one of the leading causes of death in the elderly. The most important causes of arteriosclerosis are hypertension, hyperlipidemia and smoking. Other obesity, diabetes, lack of exercise, nervousness, advanced age, family history, short temper, etc. are a...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More